Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FELINE: Losartan for NASH Fibrosis
NCT01051219Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- May 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Nonalcoholic steatohepatitis (NASH) comparing Losartan with Placebo (2 arms). Primary endpoint: Change in Kleiner fibrosis score at 24 months. Started May 2011; status: completed.
02
Drugs
losartan
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01051219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051219.